Peter Kaiser, MD
Enriched profileChaney Family Endowed Chair in Ophthalmology Research; Professor of Ophthalmology, Cleveland Clinic Lerner College of Medicine; Staff, Vitreoretinal Faculty, Cole Eye Institute · Cole Eye Institute
Peter Kaiser is Chaney Family Endowed Chair in Ophthalmology Research; Professor of Ophthalmology, Cleveland Clinic Lerner College of Medicine; Staff, Vitreoretinal Faculty, Cole Eye Institute at Cole Eye Institute. OpenAlex indexes 770 publications with 40,088 citations (h-index 82); ClinicalTrials.gov lists 4 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Ophthalmology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Peter Kaiser, MD, is Chaney Family Endowed Chair in Ophthalmology Research at Cole Eye Institute, Cleveland Clinic. The public record shows 770 publications with 40,088 citations (h-index 82), centered on Retinal Diseases and Treatments, Retinal and Macular Surgery, Retinal Imaging and Analysis. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 38 companies, 1 NIH-funded awards (2005–2006).
- Most recent indexed publication: 2026 · Journal of vitreoretinal diseases
- Top research focus: Retinal Diseases and Treatments
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 38 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 19 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 343.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- Vascular Lab Resource (VLR) Biorepository
Sponsor: The Cleveland Clinic
- Optical Coherence Tomography in Multiple Sclerosis Patients
Sponsor: The Cleveland Clinic
Industry payments
Updated 27 Aug 2026
38 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Astellas Pharma Europe LtdProgram year20251 payment
- Eli Lilly and CompanyProgram year20252 payments
- Samsung Bioepis Co., Ltd.Program year20252 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
80.4%alpha-Adrenergic Agonist20.7%Brimonidine Tartrate100%Part D<11 patientsCorticosteroid16.3%Prednisolone Acetate100%Part D<11 patientsMusculoskeletal
19.6%Cyclooxygenase Inhibitor19.6%Ketorolac Tromethamine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
1 NIH research award on record, funded 2005–2006 per NIH RePORTER. The latest:
- Harnessing Nutritional Modulation to Enhance Cancer Drug Potency
University of California-Irvine
FY2026$403,686R21CA307778
Congress activity
Updated 27 Aug 2026
1 congress contribution (2023) across ADA per OpenAlex. The most recent:
- 25-LB: Oral APX3330 Reduces the DRSS Worsening after 24-weeks of Daily Treatment—Efficacy and Safety Results of the ZETA-1 Phase 2 Trial in Diabetic Retinopathy
ADA Scientific Sessions
ADA2023Co-authorLate-breaking
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Quality Improvement in Vitreoretinal Surgery: Single-Center Report on Utility of Routine Intravenous Fluids in Pars Plana Vitrectomy.
Journal of vitreoretinal diseases
Article2026 - TALON phase IIIb study: 64 week results of brolucizumab versus aflibercept using treat-and-extend for neovascular age-related macular degeneration.
Eye (London, England)
Clinical Trial2026 - Real-World Functional and Anatomic Outcomes With Aflibercept 8.0 mg in Patients With Diabetic Macular Edema.
Journal of vitreoretinal diseases
Article2025 - Impact of Central Subfield Thickness Fluctuations on Visual Outcomes in Neovascular Age-Related Macular Degeneration in the VIEW Trials.
Journal of vitreoretinal diseases
Article2025
Most-cited works
by citation count (OpenAlex)- 01Ranibizumab for Neovascular Age-Related Macular Degeneration5,873 citations2006
- 02
- 03
- 04
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/peter-kaiser-md-2e4b127b
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
asrs.org/patients/retina-health-for-life-podcast
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →providers.clevelandclinic.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →providers.clevelandclinic.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →providers.clevelandclinic.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →providers.clevelandclinic.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →providers.clevelandclinic.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →providers.clevelandclinic.org ↗
Editorial & leadership roles
journal and society appointments- Founding Director
Digital Optical Coherence Tomography (OCT) Reading Center, Cole Eye Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.clevelandclinic.org ↗ - Team ophthalmologist
Cleveland Cavaliers (NBA)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →theorg.com ↗ - Team ophthalmologist
Cleveland Browns (NFL) and Cleveland Guardians (MLB)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.clevelandclinic.org ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →providers.clevelandclinic.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →my.clevelandclinic.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗
Secondary affiliations
appointments beyond the home institution- Professor of Ophthalmology
Case Western Reserve University School of Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →asrs.org ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →retinatoday.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Ali Bijani
Babol University of Medical Sciences
Hamid Asayesh
Ayatollah Boroujerdi University
John J. Huang
Isfahan University of Medical Sciences
Fotis Topouzis
National University of Singapore